MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹9,919 Cr | ₹8,012 Cr | ₹6,735 Cr | ₹5,304 Cr | ₹4,065 Cr |
What is the latest Profit & Loss Account Balance ratio of MANKIND PHARMA ?
Year | Profit & Loss Account Balance |
---|---|
Mar2024 | ₹9,919 Cr |
Mar2023 | ₹8,012 Cr |
Mar2022 | ₹6,735 Cr |
Mar2021 | ₹5,304 Cr |
Mar2020 | ₹4,065 Cr |
How is Profit & Loss Account Balance of MANKIND PHARMA Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2024 | ₹9,919 Cr | 23.80 | |
Mar2023 | ₹8,012 Cr | 18.96 | |
Mar2022 | ₹6,735 Cr | 26.99 | |
Mar2021 | ₹5,304 Cr | 30.45 | |
Mar2020 | ₹4,065 Cr | - |
Compare Profit & Loss Account Balance of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹115,670.3 Cr | 4.2% | 9.8% | 49.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 4.2% |
9.8% |
49.8% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses